{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:06:16Z","timestamp":1771052776199,"version":"3.50.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1212\/wnl.51.3.899","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:35:51Z","timestamp":1336916151000},"page":"899-901","source":"Crossref","is-referenced-by-count":48,"title":["Brain infarction following 5-fluorouracil and cisplatin therapy"],"prefix":"10.1212","volume":"51","author":[{"given":"M.","family":"El Amrani","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (Drs. El Amrani, Bousser, and Amarenco), Saint-Antoine Hospital, and Tenon Hospital (Drs. Heinzlef and Roullet), Pierre and Marie Curie University, Paris; Delafontaine Hospital (Dr. Debroucker), Saint-Denis; and the Department of Neurology (Drs. El Amrani, Bousser, and Amarenco), Lariboisie\u0300re Hospital, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Heinzlef","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. El Amrani, Bousser, and Amarenco), Saint-Antoine Hospital, and Tenon Hospital (Drs. Heinzlef and Roullet), Pierre and Marie Curie University, Paris; Delafontaine Hospital (Dr. Debroucker), Saint-Denis; and the Department of Neurology (Drs. El Amrani, Bousser, and Amarenco), Lariboisie\u0300re Hospital, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Debrouker","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. El Amrani, Bousser, and Amarenco), Saint-Antoine Hospital, and Tenon Hospital (Drs. Heinzlef and Roullet), Pierre and Marie Curie University, Paris; Delafontaine Hospital (Dr. Debroucker), Saint-Denis; and the Department of Neurology (Drs. El Amrani, Bousser, and Amarenco), Lariboisie\u0300re Hospital, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E\u0301.","family":"Roullet","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. El Amrani, Bousser, and Amarenco), Saint-Antoine Hospital, and Tenon Hospital (Drs. Heinzlef and Roullet), Pierre and Marie Curie University, Paris; Delafontaine Hospital (Dr. Debroucker), Saint-Denis; and the Department of Neurology (Drs. El Amrani, Bousser, and Amarenco), Lariboisie\u0300re Hospital, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Bousser","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. El Amrani, Bousser, and Amarenco), Saint-Antoine Hospital, and Tenon Hospital (Drs. Heinzlef and Roullet), Pierre and Marie Curie University, Paris; Delafontaine Hospital (Dr. Debroucker), Saint-Denis; and the Department of Neurology (Drs. El Amrani, Bousser, and Amarenco), Lariboisie\u0300re Hospital, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Amarenco","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. El Amrani, Bousser, and Amarenco), Saint-Antoine Hospital, and Tenon Hospital (Drs. Heinzlef and Roullet), Pierre and Marie Curie University, Paris; Delafontaine Hospital (Dr. Debroucker), Saint-Denis; and the Department of Neurology (Drs. El Amrani, Bousser, and Amarenco), Lariboisie\u0300re Hospital, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198501000-00001"},{"key":"e_1_3_1_3_2","first-page":"9","volume":"107","year":"1993","unstructured":"Bachaud JM, David JM, Shubinski RE, et al. Predictive factors of a complete response to an adverse effect of a CDDP-5FU combination as primary therapy for head and neck squamous carcinomas. J Laryngol Otol 1993;107:924-930.","journal-title":"J Laryngol Otol"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.1.1"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"15","year":"1992","unstructured":"Kelly MA, Gorelick PB, Mirza D. The role of drugs in the etiology of stroke. Clin Neuropharmacol 1992;15:249-275.","journal-title":"Clin Neuropharmacol"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930701)72:1<5::AID-CNCR2820720104>3.0.CO;2-Y"},{"key":"e_1_3_1_7_2","first-page":"5","volume":"14","year":"1991","unstructured":"Atkins JN, Muss HB, Case D, et al. High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association. Am J Clin Oncol 1991;14:526-529.","journal-title":"Am J Clin Oncol"},{"key":"e_1_3_1_8_2","first-page":"2","volume":"14","year":"1996","unstructured":"Pritchard KI, Paterson AHG, Paul NA, Zee B, Fine S, Pater J, for the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. J Clin Oncol 1996;14:2731-2737.","journal-title":"J Clin Oncol"},{"key":"e_1_3_1_9_2","first-page":"7","volume":"71","year":"1987","unstructured":"Collins C, Welden PL. Cardiotoxicity of 5-fluorouracil. Cancer Treat Rep 1987;71:733-736.","journal-title":"Cancer Treat Rep"},{"key":"e_1_3_1_10_2","first-page":"4","volume":"13","year":"1988","unstructured":"Eskilsson J, Albertsson M, Mercke C. Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil. Radiother Oncol 1988;13:41-46.","journal-title":"Radiother Oncol"},{"key":"e_1_3_1_11_2","first-page":"4","volume":"114","year":"1987","unstructured":"Burger A, Mannino S. 5-Fluorouracil induced coronary vasospasm. Am Heart J 1987;114:433-436.","journal-title":"Am Heart J"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.3.899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:44:59Z","timestamp":1711550699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.3.899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1212\/WNL.51.3.899"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.3.899","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}